524 related articles for article (PubMed ID: 38188647)
1. Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.
Ding J; Ding X; Liao W; Lu Z
Mater Today Bio; 2024 Feb; 24():100913. PubMed ID: 38188647
[TBL] [Abstract][Full Text] [Related]
2. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
[TBL] [Abstract][Full Text] [Related]
5. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
Xia Q; Zhang Y; Li Z; Hou X; Feng N
Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
[TBL] [Abstract][Full Text] [Related]
8. Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors.
Liu WS; Wu LL; Chen CM; Zheng H; Gao J; Lu ZM; Li M
Mater Today Bio; 2023 Oct; 22():100751. PubMed ID: 37636983
[TBL] [Abstract][Full Text] [Related]
9. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
Tian X; Shi A; Wu J
Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics.
Wang S; Wang Y; Jin K; Zhang B; Peng S; Nayak AK; Pang Z
Expert Opin Drug Deliv; 2022 Aug; 19(8):965-984. PubMed ID: 35917435
[TBL] [Abstract][Full Text] [Related]
11. Hybrid liposome-erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation.
Zhu K; Xu Y; Zhong R; Li W; Wang H; Wong YS; Venkatraman S; Liu J; Cao Y
Regen Biomater; 2023; 10():rbad045. PubMed ID: 37250975
[TBL] [Abstract][Full Text] [Related]
12. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
Glassman PM; Hood ED; Ferguson LT; Zhao Z; Siegel DL; Mitragotri S; Brenner JS; Muzykantov VR
Adv Drug Deliv Rev; 2021 Nov; 178():113992. PubMed ID: 34597748
[TBL] [Abstract][Full Text] [Related]
13. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles.
Bai YT; Zhang XQ; Chen XJ; Zhou G
Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844
[TBL] [Abstract][Full Text] [Related]
15. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
[TBL] [Abstract][Full Text] [Related]
16. Cell Membrane-Camouflaged Nanocarriers with Biomimetic Deformability of Erythrocytes for Ultralong Circulation and Enhanced Cancer Therapy.
Miao Y; Yang Y; Guo L; Chen M; Zhou X; Zhao Y; Nie D; Gan Y; Zhang X
ACS Nano; 2022 Apr; 16(4):6527-6540. PubMed ID: 35426300
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
[TBL] [Abstract][Full Text] [Related]
18. Application of Biomimetic Nanoparticles based on the Cell Membrane in Tumor Therapy.
Gong Y; Huang J
Curr Top Med Chem; 2023; 23(10):907-920. PubMed ID: 37102484
[TBL] [Abstract][Full Text] [Related]
19. Cell membrane-based biomimetic technology for cancer phototherapy: Mechanisms, recent advances and perspectives.
Li S; Meng X; Peng B; Huang J; Liu J; Xiao H; Ma L; Liu Y; Tang J
Acta Biomater; 2024 Jan; 174():26-48. PubMed ID: 38008198
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system.
Liu H; Su YY; Jiang XC; Gao JQ
Drug Deliv Transl Res; 2023 Mar; 13(3):716-737. PubMed ID: 36417162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
